<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03700346</url>
  </required_header>
  <id_info>
    <org_study_id>MilitaryHospTunis</org_study_id>
    <nct_id>NCT03700346</nct_id>
  </id_info>
  <brief_title>Muscle Lactate and Lactate to Pyruvate Ratio Clearance in Septic Shock Patients</brief_title>
  <acronym>ClMLsepsis</acronym>
  <official_title>Muscle Lactate and Lactate to Pyruvate Ratio Clearance as Useful Biomarkers for the Prediction of Mortality in Septic Shock Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Military Hospital of Tunis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Military Hospital of Tunis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We conducted this study aiming to assess the performance of muscle Lactate and lactate to&#xD;
      pyruvate (L/P) ratio clearance in predicting mortality in septic shock patients by using&#xD;
      microdialysis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Microcirculatory alterations are frequently observed in patients with sepsis. In vivo&#xD;
      microdialysis (MD) is a bedside technique that can monitor tissue metabolic changes. We&#xD;
      conducted this study aiming to assess the performance of muscle Lactate and lactate to&#xD;
      pyruvate (L/P) ratio clearance in predicting mortality in septic shock patients by using&#xD;
      microdialysis.&#xD;
&#xD;
      Interstitial tissue concentrations of lactate, pyruvate, glucose and glycerol were obtained&#xD;
      at baseline and every 6 hours for 3 days by using muscle microdialysis. Clearances of muscle&#xD;
      lactate, and L/P ratio were defined as the percentage change in muscle lactate level or L/P&#xD;
      ratio compared to baseline (H0) values. A positive value of clearance means a decrease in the&#xD;
      rate of the parameter under study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">October 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clearances of muscle lactate, and L/P ratio</measure>
    <time_frame>3 days</time_frame>
    <description>Clearances of muscle lactate, and L/P ratio were defined as the percentage change in muscle lactate level or L/P ratio compared to baseline (H0) values.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>muscle lactate</measure>
    <time_frame>3 days</time_frame>
    <description>Interstitial tissue concentration of lactate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle pyruvate</measure>
    <time_frame>3 days</time_frame>
    <description>Interstitial tissue concentration of pyruvate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle glucose</measure>
    <time_frame>3 days</time_frame>
    <description>Interstitial tissue concentration of glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle glycerol</measure>
    <time_frame>3 days</time_frame>
    <description>Interstitial tissue concentration of glycerol</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>survivors</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>survivor at ICU discharge muscle microdialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non survivors</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>death before ICU discharge muscle microdialysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>microdialysis</intervention_name>
    <description>Interstitial tissue concentrations of lactate, pyruvate, glucose and glycerol were obtained by using muscle microdialysis</description>
    <arm_group_label>Non survivors</arm_group_label>
    <arm_group_label>survivors</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients fulfilled the criteria of septic shock&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy, uncontrolled hemorrhage, terminal heart failure, significant valvular heart&#xD;
             disease, documented or suspected acute coronary syndrome, and limitations on the use&#xD;
             of inotropes: left ventricle outflow obstruction, systolic anterior motion of the&#xD;
             mitral valve.&#xD;
&#xD;
          -  incomplete data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>zied Hajjej, dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Military hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Military hospital of tunis</name>
      <address>
        <city>Tunis</city>
        <state>Mont Fleury</state>
        <zip>1008</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Military Hopital of Tunis</name>
      <address>
        <city>Tunis</city>
        <zip>1008</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>September 30, 2018</study_first_submitted>
  <study_first_submitted_qc>October 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2018</study_first_posted>
  <last_update_submitted>April 18, 2021</last_update_submitted>
  <last_update_submitted_qc>April 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

